Abstract
Lead optimization requires rapid bio-analytical turnover for the generation of early absorption, distribution, metabolism, excretion (ADME) and pharmacokinetics (PK) data maintaining a high quality level. Therefore, one of the major challenges in the bio-analytical field is to achieve faster and more sensitive quantification protocols. In the present communication, a comparison between HPLC and ultra performance liquid chromatography (UPLC) performances in terms of sensitivity and resolution is shown using a pharmakokinetic study and a metabolism study as models. The studies highlight the features of the new technology and the resulting impact in the PK throughput and in the characterization of isomeric metabolites using UPLC/MS/MS technique.
Publication types
-
Comparative Study
-
Evaluation Study
MeSH terms
-
Administration, Oral
-
Animals
-
Benzamides / administration & dosage
-
Benzamides / blood
-
Benzamides / chemistry
-
Benzamides / metabolism*
-
Benzamides / pharmacokinetics*
-
Benzamides / pharmacology
-
Calibration
-
Cells, Cultured
-
Chromatography, High Pressure Liquid / methods*
-
Cryopreservation
-
Dogs
-
Drug Evaluation, Preclinical
-
Female
-
Hepatocytes / drug effects*
-
Hepatocytes / metabolism
-
In Vitro Techniques
-
Indoles / administration & dosage
-
Indoles / blood
-
Indoles / chemistry
-
Indoles / metabolism*
-
Indoles / pharmacokinetics*
-
Indoles / pharmacology
-
Injections, Intravenous
-
Metabolic Clearance Rate
-
Mice
-
Mice, Nude
-
Molecular Structure
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Tandem Mass Spectrometry*
-
Verapamil / metabolism
-
Verapamil / pharmacokinetics
Substances
-
4-(5,6-dichloro-1H-indol-2-yl)-3-ethoxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzamide
-
Benzamides
-
Indoles
-
Verapamil